Conjupro Biotherapeutics, Inc.
Clinical trials sponsored by Conjupro Biotherapeutics, Inc., explained in plain language.
-
Experimental drug targets Tough-to-Treat cancers in groundbreaking trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called SYS6043 in adults with advanced solid tumors that have spread or stopped responding to standard treatments. The main goals are to find the safest dose, understand side effects, and see how the drug moves through the body. Resear…
Phase: PHASE1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New weapon against advanced cancer begins human testing
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new experimental drug called CPO301 in adults with advanced or metastatic solid tumors that have stopped responding to standard treatments. The drug is designed to target and deliver a toxic payload sp…
Phase: PHASE1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New cancer drug enters first human trials
Disease control Recruiting nowThis is an early-stage study testing a new drug called JMT108 in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug shows any early signs of helping to shrink tumors. Participants will recei…
Phase: PHASE1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC